Clinical trial Recruiting at 2 sites Observational Ages 5 to 40

Detecting hidden small airway issues in cystic fibrosis patients

Official title: The Measurement and Analysis of Maximal Expiratory Flow Volume Loops at Low Lung Volumes in Children With Cystic Fibrosis and Normal Routine Lung Function.

Run by Gelb, Arthur F., M.D. · NCT03839992 · Data updated 2026-11-12

This study is trying to find hidden breathing problems in children and adults with cystic fibrosis who seem healthy on standard lung tests by looking at their lung scans and airflow patterns.

More Cystic Fibrosis trials

Quick facts

Study typeObservational
Ages5 Years to 40 Years
SexAll
Enrollment100 (estimated)
SponsorGelb, Arthur F., M.D.
Indiv
Locations2 sites (Lakewood, California and 1 other locations)
StatusRecruiting
StartedApril 25, 2018
Main results expectedApril 25, 2027
Study endsNovember 25, 2027
Registry record updatedOctober 26, 2023
Trial IDNCT03839992 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are heterozygous or homozygous cystic fibrosis patients with normal pre bronchodilator spirometry results.

Probably not a fit

Patients with abnormal routine pre bronchodilator spirometry results will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify unsuspected small airways obstruction in children and adults with cystic fibrosis who have normal routine spirometry results. It utilizes retrospective analysis based on previous research that demonstrated the ability to detect airflow limitations at low lung volumes, despite normal FEV1 and FVC values. The study focuses on the correlation between abnormal expiratory airflow and the presence of bronchiectasis as shown in lung CT scans. By analyzing these factors, the researchers hope to improve the understanding of lung function in cystic fibrosis patients.

Why it matters

Potential benefit: If successful, this study could lead to earlier detection and better management of lung complications in cystic fibrosis patients.

How similar studies have gone: Previous studies have shown success in detecting small airway obstruction using similar methodologies, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Heterozygote or homozygote patients with cystic fibrosis with normal routine pre bronchodilator spirometry including normal FEV1(L), FVC(L) and FEV1/FVC%.

Exclusion Criteria:Heterozygote or homozygote patients with cystic fibrosis with ABNORMAL routine pre bronchodilator spirometry

\-

Where it's running

  • Arthur F Gelb MD
    Lakewood, California, United States
    Recruiting
  • Miller Children's Hospital and Long Beach Medical Center
    Long Beach, California, United States
    Recruiting

Study contacts

  • Principal investigator: Arthur Gelb, MD — University of California, Los Angeles
  • Study coordinator: Arthur F Gelb, MD
  • Email: afgelb@msn.com
  • Phone: 562-565-5333

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.